On behalf of the Vice President for Research, the University Research Compliance Officer ("RCO") acts to oversee and ensure research compliance with regulations applicable to the use of human and animal subjects, biosafety and pre-award grants administration. In this capacity, the RCO ensures that all research conducted at the University adheres to the applicable federal and state regulations. This goal is accomplished by working with the Office of Research Administration and with the compliance committees governing animal use, biosafety, human research protections and radiation use. Additionally, the RCO serves as the university's Research Integrity Officer (RIO).
Brian J. Weimer, JD
1440 Canal Street
Suite 2425, TW5
New Orleans, LA 70112
Administrative Assistant to the University Research Compliance Officer: Kay Leger
Research Compliance Hotline: (504) 988-1147
Comments, concerns, requests, and reports regarding suspected compliance issues, including research misconduct, may be made by contacting the Research Compliance Office (RCO) at (504) 988-1147 or via e-mail at firstname.lastname@example.org. This phone number and e-mail are answered only by RCO personnel. When personnel are not available, calls are forwarded to a confidential voice mailbox maintained by the RCO. Anyone reporting concerns via the phone or e-mail have the right to remain anonymous. To the extent possible within the limitations of law and regulation, all information will be treated and maintained as confidential. Any individual may make a complaint in good faith without the fear of reprisal.
All other allegations of Research Misconduct, including those involving students and staff, are governed by the Tulane Research Misconduct Policy, located in the Tulane Faculty Handbook Section III(H)
NIH PUBLIC ACCESS POLICY: The NIH public access policy requires that authors of articles arising from NIH-funded research must submit to PubMed Central an electronic copy of their final peer-peer reviewed manuscripts if 1) the manuscript is accepted for publication in a journal on or after April 7, 2008 and arises from research funded by an NIH grant or cooperative agreement active in the NIH Fiscal year 2008 or later (Oct 1, 2007 or later); or 2) the manuscript is accepted for publication and arises from research funded by an NIH grant or cooperative agreement that is dated on or after April 7, 2008. Attached is a letter for use by Tulane authors notifying publishers that an article being submitted for consideration is based on NIH-funded research and therefore must be made accessible to the public under the NIH’s public access policy.
1440 Canal Street Suite, 2400, TW-5, New Orleans, LA 70112 504-988-3291 email@example.com